We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.8%
3 Healthcare 9.84%
4 Communication Services 9.47%
5 Financials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRZU icon
6101
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$90M
-16
Closed -$1K
BSBR icon
6102
Santander
BSBR
$43.1B
-9,427
Closed -$50K
BSCP
6103
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
-100
Closed -$2K
BSJS icon
6104
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$743M
-82
Closed -$2K
BSVN icon
6105
Bank7 Corp
BSVN
$486M
-1,151
Closed -$27K
BTT icon
6106
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
-14
Closed
BURU
6107
DELISTED
NUBURU INC
BURU
-4
Closed -$7K
BVN icon
6108
Compañía de Minas Buenaventura
BVN
$8.84B
-1,466
Closed -$11K
BWEN icon
6109
Broadwind
BWEN
$125M
$0 ﹤0.01%
44
-1,387
-97% -$2.7K
BXMX
6110
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
-300
Closed -$4K
CADL icon
6111
Candel Therapeutics
CADL
$780M
$0 ﹤0.01%
+54
New +$268
CALC icon
6112
CalciMedica
CALC
$10.4M
$0 ﹤0.01%
14
-158
-92% -$3.01K
CANG
6113
Cango Inc
CANG
$70.6M
-215
Closed -$7K
CAPL icon
6114
CrossAmerica Partners
CAPL
$856M
-574
Closed -$11K
CAPR icon
6115
Capricor Therapeutics
CAPR
$228M
-1,277
Closed -$4K
CARV
6116
DELISTED
Carver Bancorp
CARV
$0 ﹤0.01%
+75
New +$568
CCAP icon
6117
Crescent Capital BDC
CCAP
$422M
-754
Closed -$13K
CCD
6118
Calamos Dynamic Convertible & Income Fund
CCD
$745M
$0 ﹤0.01%
+16
New +$429
CCU icon
6119
Compañía de Cervecerías Unidas
CCU
$2.22B
-2,680
Closed -$44K
CDC icon
6120
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$744M
-353
Closed -$25K
CDIO icon
6121
Cardio Diagnostics
CDIO
$5.42M
0
CDROW icon
6122
Codere Online Luxembourg Warrants
CDROW
$0 ﹤0.01%
78
CEE
6123
Central and Eastern Europe Fund
CEE
$139M
-235
Closed -$6K
CEFS icon
6124
Saba Closed-End Funds ETF
CEFS
$437M
-75
Closed -$2K
CHT icon
6125
Chunghwa Telecom
CHT
$32.9B
-5,253
Closed -$222K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.